Invention Grant
- Patent Title: Humanized non-human animals with restricted immunoglobulin heavy chain loci
-
Application No.: US16222951Application Date: 2018-12-17
-
Publication No.: US10542735B2Publication Date: 2020-01-28
- Inventor: Lynn Macdonald , Naxin Tu , Sean Stevens , Andrew J. Murphy , Margaret Karow
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regerneron Pharmaceuticals, Inc.
- Current Assignee: Regerneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Choate, Hall & Stewart LLP
- Agent Brenda Herschbach Jarrell; Stephanie L. Schonewald
- Main IPC: A01K67/027
- IPC: A01K67/027 ; C12P21/02 ; C07K16/46

Abstract:
Mice, embryos, cells, and tissues having a restricted immunoglobulin heavy chain locus and an ectopic sequence encoding one or more ADAM6 proteins are provided. In various embodiments, mice are described that have humanized endogenous immunoglobulin heavy chain loci and are capable of expressing an ADAM6 protein or ortholog or homolog or functional fragment thereof that is functional in a male mouse. Mice, embryos, cells, and tissues having an immunoglobulin heavy chain locus characterized by a single human VH gene segment, a plurality of human DH gene segments and a plurality of human JH gene segments and capable expressing an ADAM6 protein or ortholog or homolog or functional fragment thereof are also provided.
Public/Granted literature
- US20190200588A1 HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI Public/Granted day:2019-07-04
Information query